The analysis also discusses the regulatory alternatives FDA considered in drafting the proposed rule.
The regulatory alternatives FDA considered in drafting the proposed rule are also discussed in the analysis.
mnli hypothesis: The regulatory alternatives FDA considered in drafting the proposed rule are also discussed in the analysis. premise: The analysis also discusses the regulatory alternatives FDA considered in drafting the proposed rule.